NDC 50090-0072

Cephalexin

Cephalexin

Cephalexin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Cephalexin.

Product ID50090-0072_322c777a-a463-44b0-90e2-b93927de8439
NDC50090-0072
Product TypeHuman Prescription Drug
Proprietary NameCephalexin
Generic NameCephalexin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2006-01-11
Marketing CategoryANDA / ANDA
Application NumberANDA065229
Labeler NameA-S Medication Solutions
Substance NameCEPHALEXIN
Active Ingredient Strength250 mg/1
Pharm ClassesCephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 50090-0072-2

20 CAPSULE in 1 BOTTLE (50090-0072-2)
Marketing Start Date2014-11-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-0072-3 [50090007203]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA065229
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-09-08
Marketing End Date2019-12-31

NDC 50090-0072-5 [50090007205]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA065229
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-09-08
Marketing End Date2019-11-30

NDC 50090-0072-4 [50090007204]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA065229
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-09-08
Marketing End Date2019-12-31

NDC 50090-0072-2 [50090007202]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA065229
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28
Marketing End Date2019-12-31

NDC 50090-0072-8 [50090007208]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA065229
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-09-08
Marketing End Date2019-12-31

Drug Details

Active Ingredients

IngredientStrength
CEPHALEXIN250 mg/1

OpenFDA Data

SPL SET ID:9e3ab9b6-ed70-43d6-bf64-5631517f65fd
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 309112
  • 309114

    • Pharmacological Class

    • Cephalosporin Antibacterial [EPC]
    • Cephalosporins [CS]

    NDC Crossover Matching brand name "Cephalexin" or generic name "Cephalexin"

    NDCBrand NameGeneric Name
    0093-2238CephalexinCephalexin
    0093-2240CephalexinCephalexin
    0093-3145CephalexinCephalexin
    0093-3147CephalexinCephalexin
    0093-4175CephalexinCephalexin
    0093-4177CephalexinCephalexin
    0143-9769CephalexinCephalexin
    0143-9770CephalexinCephalexin
    0143-9897CephalexinCephalexin
    0143-9898CephalexinCephalexin
    67877-220CephalexinCephalexin
    67877-254CephalexinCephalexin
    67877-255CephalexinCephalexin
    67877-219CephalexinCephalexin
    68071-1585CephalexinCephalexin
    68071-4177CephalexinCephalexin
    68071-3186CephalexinCephalexin
    68071-4355CephalexinCephalexin
    68071-4342CephalexinCephalexin
    68071-4465CephalexinCephalexin
    68071-4233CephalexinCephalexin
    68071-4406CephalexinCephalexin
    68071-4429CephalexinCephalexin
    68071-4587CephalexinCephalexin
    68071-4516CephalexinCephalexin
    68071-4434CephalexinCephalexin
    0440-1243CephalexinCephalexin
    0440-7244CephalexinCephalexin
    68180-124cephalexincephalexin
    68180-441cephalexincephalexin
    68180-121CephalexinCephalexin
    68180-123cephalexincephalexin
    68180-440cephalexincephalexin
    68180-122CephalexinCephalexin
    68788-8986CephalexinCephalexin
    68788-9404CephalexinCephalexin
    68788-7271CephalexinCephalexin
    68788-9713CephalexinCephalexin
    68788-9326CephalexinCephalexin
    68788-9951cephalexincephalexin
    68788-8994CephalexinCephalexin
    68788-7391CephalexinCephalexin
    68788-9539CephalexinCephalexin
    68788-9950cephalexincephalexin
    68788-9956cephalexincephalexin
    68788-9538CephalexinCephalexin
    68788-9752cephalexincephalexin
    68788-9957cephalexincephalexin
    69543-102CephalexinCephalexin
    69778-930CephalexinCephalexin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.